
Breaking Barriers or Building Bias? The Controversial Debate on Diversity in Clinical Trials
In January 2025, the FDA quietly removed its draft guidance on diversity inclusion in clinical trials from its website, marking a significant shift in the regulatory landscape. This guidance, originally